HIV Cure: Where have we been, where are we going? - Daniel Kuritzkes, MD

International Workshop on HIV & Women 2019

Systematic Review and Meta-Analysis of Adverse Perinatal Outcomes Associated With Prenatal Exposure to Protease Inhibitor Combination in Pregnant Women With HIV Infection

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020

Hepatitis B and C viral markers screening during blood collection for transfusion to allow primary and secondary prevention of liver disease.

Conference on Liver Disease in Africa (COLDA) 2019

#6_ElizabethChappell_Incidence of SARS-CoV-2 Infection and Clinical Characteristics in Children and Young People Living With HIV in Europe_Slides

International Workshop on HIV & Pediatrics 2022

Enduring Materials | Slides | Dr. Boffito | NURSHCF2020

Nurses & Pharmacists HIV Clinical Forum 2020

Mental health in HIV care | Jordi Blanch, MD, PhD

European Workshop on Healthy Living with HIV 2018

The Impact of Antiretroviral Drug Resistance in Taiwanese HIV-1-Infected MSM Population Between 2015 and 2018 - Yen-Ju Chen

Asia-Pacific HIV Clinical Forum 2019

Neoepitope fragments of extracellular matrix as markers of fibrosis in chronic liver disease: Insights into clinical and preclinical utilization for unfolding disease pathogenesis - Diana Leeming, PhD

International Workshop on NASH Biomarkers 2018

Has treating HBV reduced liver cancer incidence? - Jinlin Hou, MD

Asian Conference on Hepatitis and AIDS (ACHA) 2014

Entry inhibition- Stephan Urban, PhD

International Workshop on HBV Cure 2017